4.6 Article

International validation of Enhanced Recovery After Surgery Society guidelines on enhanced recovery for gynecologic surgery

Journal

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2019.04.028

Keywords

compliance; ERAS; gynecologic surgery; gynecologic oncology; length of stay; perioperative care

Funding

  1. Research Committee of orebro County Council
  2. Reproductive Scientist Development Program [NICHD K12HD00849]

Ask authors/readers for more resources

BACKGROUND: Enhanced Recovery After Surgery Society publishes guidelines on perioperative care, but these guidelines should be validated prospectively. OBJECTIVE: To evaluate the association between compliance with Enhanced Recovery After Surgery Gynecologic/Oncology guideline elements and postoperative outcomes in an international cohort. STUDY DESIGN: The study comprised 2101 patients undergoing elective gynecologic/oncology surgery between January 2011 and November 2017 in 10 hospitals across Canada, the United States, and Europe. Patient demographics, surgical/anesthesia details, and Enhanced Recovery After Surgery protocol compliance elements (pre-, intra-, and postoperative phases) were entered into the Enhanced Recovery After Surgery Interactive Audit System. Surgical complexity was stratified according to the Aletti scoring system (low vs medium/high). The following covariates were accounted for in the analysis: age, body mass index, smoking status, presence of diabetes, American Society of Anesthesiologists class, International Federation of Gynecology and Obstetrics stage, preoperative chemotherapy, radiotherapy, operating time, surgical approach (open vs minimally invasive), intraoperative blood loss, hospital, and Enhanced Recovery After Surgery implementation status. The primary end points were primary hospital length of stay and complications. Negative binomial regression was used to model length of stay, and logistic regression to model complications, as a function of compliance score and covariates. RESULTS: Patient demographics included a median age 56 years, 35.5% obese, 15% smokers, and 26.7% American Society of Anesthesiologists Class III-IV. Final diagnosis was malignant in 49% of patients. Laparotomy was used in 75.9% of cases, and the remainder minimally invasive surgery. The majority of cases (86%) were of low complexity (Aletti score <= 3). In patients with ovarian cancer, 69.5% had a medium/high complexity surgery (Aletti score 4-11). Median length of stay was 2 days in the low- and 5 days in the medium/high-complexity group. Every unit increase in Enhanced Recovery After Surgery guideline score was associated with 8% (IRR, 0.92; 95% confidence interval, 0.90-0.95; P<.001) decrease in days in hospital among low-complexity, and 12% (IRR, 0.88; 95% confidence interval, 0.82-0.93; P<.001) decrease among patients with medium/high-complexity scores. For every unit increase in Enhanced Recovery After Surgery guideline score, the odds of total complications were estimated to be 12% lower (P<.05) among low-complexity patients. CONCLUSION: Audit of surgical practices demonstrates that improved compliance with Enhanced Recovery After Surgery Gynecologic/Oncology guidelines is associated with an improvement in clinical outcomes, including length of stay, highlighting the importance of Enhanced Recovery After Surgery implementation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

Eun-Young Kang, Ashley Weir, Nicola S. Meagher, Kyo Farrington, Gregg S. Nelson, Prafull Ghatage, Cheng-Han Lee, Marjorie J. Riggan, Adelyn Bolithon, Gordana Popovic, Betty Leung, Katrina Tang, Neil Lambie, Joshua Millstein, Jennifer Alsop, Michael S. Anglesio, Beyhan Ataseven, Ellen Barlow, Matthias W. Beckmann, Jessica Berger, Christiani Bisinotto, Hans Boesmueller, Jessica Boros, Alison H. Brand, Angela Brooks-Wilson, Sara Y. Brucker, Michael E. Carney, Yovanni Casablanca, Alicia Cazorla-Jimenez, Paul A. Cohen, Thomas P. Conrads, Linda S. Cook, Penny Coulson, Madeleine Courtney-Brooks, Daniel W. Cramer, Philip Crowe, Julie M. Cunningham, Cezary Cybulski, Kathleen M. Darcy, Mona A. El-Bahrawy, Esther Elishaev, Ramona Erber, Rhonda Farrell, Sian Fereday, Anna Fischer, Maria J. Garcia, Simon A. Gayther, Aleksandra Gentry-Maharaj, C. Blake Gilks, Marcel Grube, Paul R. Harnett, Shariska Petersen Harrington, Philipp Harter, Arndt Hartmann, Jonathan L. Hecht, Sebastian Heikaus, Alexander Hein, Florian Heitz, Joy Hendley, Brenda Y. Hernandez, Susanna Hernando Polo, Sabine Heublein, Akira Hirasawa, Estrid Hogdall, Claus K. Hogdall, Hugo M. Horlings, David G. Huntsman, Tomasz Huzarski, Andrea Jewell, Mercedes Jimenez-Linan, Michael E. Jones, Scott H. Kaufmann, Catherine J. Kennedy, Dineo Khabele, Felix K. F. Kommoss, Roy F. P. M. Kruitwagen, Diether Lambrechts, Nhu D. Le, Marcin Lener, Jenny Lester, Yee Leung, Anna Linder, Liselore Loverix, Jan Lubinski, Rashna Madan, G. Larry Maxwell, Francesmary Modugno, Susan L. Neuhausen, Alexander Olawaiye, Siel Olbrecht, Sandra Orsulic, Jose Palacios, Celeste Leigh Pearce, Malcolm C. Pike, Carmel M. Quinn, Ganendra Raj Mohan, Cristina Rodriguez-Antona, Matthias Ruebner, Andy Ryan, Stuart G. Salfinger, Naoko Sasamoto, Joellen M. Schildkraut, Minouk J. Schoemaker, Mitul Shah, Raghwa Sharma, Yurii B. Shvetsov, Naveena Singh, Gabe S. Sonke, Linda Steele, Colin J. R. Stewart, Karin Sundfeldt, Anthony J. Swerdlow, Aline Talhouk, Adeline Tan, Sarah E. Taylor, Kathryn L. Terry, Aleksandra Toloczko, Nadia Traficante, Koen K. Van de Vijver, Maaike A. van der Aa, Toon Van Gorp, Els Van Nieuwenhuysen, Lilian Van-Wagensveld, Ignace Vergote, Robert A. Vierkant, Chen Wang, Lynne R. Wilkens, Stacey J. Winham, Anna H. Wu, Javier Benitez, Andrew Berchuck, Francisco J. Candido Dos Reis, Anna DeFazio, Peter A. Fasching, Ellen L. Goode, Marc T. Goodman, Jacek Gronwald, Beth Y. Karlan, Stefan Kommoss, Usha Menon, Hans-Peter Sinn, Annette Staebler, James D. Brenton, David D. Bowtell, Paul D. P. Pharoah, Susan J. Ramus, Martin Kobel

Summary: This study validates that high-level amplification of CCNE1 is associated with shorter survival in tubo-ovarian high-grade serous carcinoma (HGSC), supporting its use as a prognostic biomarker in this disease.

CANCER (2023)

Article Oncology

Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study

Citadel J. J. Cabasag, Melina Arnold, Mark Rutherford, Jacques Ferlay, Aude Bardot, Eileen Morgan, John Butler, Dianne L. L. O'Connell, Gregg Nelson, Claus Hogdall, Tine Schnack, Anna Gavin, Mark Elwood, Louise Hanna, Charlie Gourley, Prithwish De, Nathalie Saint-Jacques, Lina Steinrud Morch, Ryan R. Woods, Alon D. D. Altman, Peter Sykes, Paul A. A. Cohen, Orla McNally, Bjorn Moller, Paul Walsh, David S. S. Morrison, Freddie Bray, Isabelle Soerjomataram

Summary: The aim of this study was to assess the incidence and survival trends of epithelial ovarian cancer (EOC) by histological subtype across seven high-income countries. Data from 1995 to 2014 were obtained from 20 cancer registries, and results showed that there was a significant increase in serous carcinoma incidence among women aged 65 to 99 years. On the other hand, the incidence of adenocarcinoma not otherwise specified showed a marked decrease in women aged 15 to 64 years. The overall survival of EOC has improved over the 20-year study period in all countries.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Oncology

Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges-2023 update

G. Nelson, C. Fotopoulou, J. Taylor, G. Glaser, J. Bakkum-Gamez, L. A. Meyer, R. Stone, G. Mena, K. M. Elias, A. D. Altman, S. P. Bisch, P. T. Ramirez, S. C. Dowdy

Summary: This article presents the updated evidence and recommendations for implementing Enhanced Recovery After Surgery (ERAS) in gynecologic oncology surgery. It focuses on addressing implementation challenges and provides evidence-based guidelines.

GYNECOLOGIC ONCOLOGY (2023)

Review Surgery

Bibliometric analysis of academic journal recommendations and requirements for surgical and anesthesiologic adverse events reporting

Tamir N. Sholklapper, Jorge Ballon, Aref S. Sayegh, Anibal La Riva, Laura C. Perez, Sherry Huang, Michael Eppler, Gregg Nelson, Giovanni Marchegiani, Robert Hinchliffe, Luca Gordini, Marc Furrer, Michael J. Brenner, Salome Dell-Kuster, Chandra Shekhar Biyani, Nader Francis, Haytham M. A. Kaafarani, Matthias Siepe, Des Winter, Julie A. Sosa, Francesco Bandello, Robert Siemens, Jochen Walz, Alberto Briganti, Christian Gratzke, Andre L. Abreu, Mihir M. Desai, Rene Sotelo, Riaz Agha, Keith D. Lillemoe, Steven Wexner, Gary S. Collins, Inderbir Gill, Giovanni E. Cacciamani

Summary: This study assesses the prevalence and typology of perioperative adverse event reporting guidelines among surgery and anesthesiology journals. Results show that 46.5% of the queried journals recommend surgical adverse event reporting. Journals in the surgery, urology, and anesthesia categories are most likely to recommend reporting; those in the top SJR quartiles and based in Western Europe, North America, and the Middle East are also more likely to recommend.

INTERNATIONAL JOURNAL OF SURGERY (2023)

Article Oncology

Surgical margin status in relation to surgical approach in the management of early-stage cervical Cancer: A Canadian cervical Cancer collaborative (4C) study

Sabrina Piedimonte, Limor Helpman, Gregory Pond, Gregg Nelson, Janice Kwon, Alon Altman, Tomer Feigenberg, Laurie Elit, Susie Lau, Jeanelle Sabourin, Vanessa Samouelian, Karla Willows, Christa Aubrey, Ji-Hyun Jang, Ly-Ann Teo -Fortin, Norah Cockburn, Nora -Beth Saunders, Sarah Shamiya, Danielle Vicus, Marie Plante

Summary: This study aimed to determine whether close and positive surgical margins are associated with surgical approach and survival. The results showed that the surgical approach was not associated with margin status, but close margins were associated with a higher risk of death. Minimally invasive surgery was also associated with worse survival, suggesting that margin status may not be the main driver of worse survival in these cases.

GYNECOLOGIC ONCOLOGY (2023)

Article Oncology

Cost impact analysis of enhanced recovery after minimally invasive gynecologic oncology surgery

Cristina Mitric, Sarah Daisy Kosa, Soyoun Rachel Kim, Gregg Nelson, Stephane Laframboise, Genevieve Bouchard-Fortier

Summary: The implementation of a peri-operative care program based on enhanced recovery after surgery principles for minimally invasive gynecologic oncology surgery led to an improvement in same day discharge rate and significant reductions in overall costs and some surgical and post-operative visit costs.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Article Oncology

Thoracic epidural analgesia as part of an enhanced recovery program in gynecologic oncology: a prospective cohort study

Anastasios Pandraklakis, Dimitrios Haidopoulos, Theodoros Lappas, Emmanouil Stamatakis, Dimitrios Valsamidis, Maria D. Oikonomou, Dimitrios Loutradis, Alexandros Rodolakis, Steven P. Bisch, Gregg Nelson, Nikolaos Thomakos

Summary: This study evaluated the safety and effectiveness of thoracic epidural analgesia in gynecologic oncology patients undergoing laparotomy as part of the enhanced recovery after surgery (ERAS) multimodal analgesic protocol. The results showed that thoracic epidural analgesia provided better pain relief and additional benefits during the peri-operative period, improving the overall recovery experience of patients with gynecologic cancer.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Article Medicine, General & Internal

Fertility restoration in mice with chemotherapy induced ovarian failure using differentiated iPSCs

Kevin M. Elias, Nicholas W. Ng, Kh U. Dam, Ankrish Milne, Emily R. Disler, Alison Gockley, Nicole Holub, Maya L. Seshan, George M. Church, Elizabeth S. Ginsburg, Raymond M. Anchan

Summary: This study demonstrates the potential of induced pluripotent stem cell (iPSC) transplantation for the treatment of premature ovarian insufficiency (POI) in a mouse model, as it successfully reversed the endocrine and reproductive issues caused by POI.

EBIOMEDICINE (2023)

Article Oncology

Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells

Thomas J. Gerton, Allen Green, Marco Campisi, Minyue Chen, Iliana Gjeci, Navin Mahadevan, Catherine A. A. Lee, Ranjan Mishra, Ha V. Vo, Koji Haratani, Ze-Hua Li, Kathleen T. Hasselblatt, Bryanna Testino, Trevor Connor, Christine G. Lian, Kevin M. Elias, Patrick Lizotte, Elena V. Ivanova, David A. Barbie, Daniela M. Dinulescu

Summary: High-grade serous ovarian cancer (HGSOC) is a leading cause of gynecology cancer-related deaths. Utilizing epigenetic modulators can maximize the effectiveness of personalized immuno-oncology treatments. The use of patient-derived tumor ascites in a 3D screening platform has shown that epigenetic priming can enhance immune checkpoint blockade therapies.

CANCERS (2023)

Article Obstetrics & Gynecology

Geographical Health District and Distance Traveled Influence on Clinical Status at Admission of Patients with Gestational Trophoblastic Disease

Valdete Aparecida Ribeiro da Silva, Izildinha Maesta, Roberto Antonio de Araujo Costa, Alinede Avila Campos, Antonio Braga, Neil Horowitz, Kevin M. Elias, Ross Berkowitz

Summary: This study examined the relationship between clinical status upon admission and distance traveled in women with gestational trophoblastic disease (GTD). The results showed that patients from areas outside the specialized center were more likely to have higher risk scores for hydatidiform mole and gestational trophoblastic neoplasia at admission. Long distances seemed to hinder access to specialized centers and negatively impact clinical status.

REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA (2023)

Review Medicine, General & Internal

Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia- systematic review with a presentation of the first 4 Brazilian cases

Antonio Braga, Elaine Balthar, Lais Cristhine Santos Souza, Michelle Samora, Matheus Rech, Jose Mauro Madi, Joffre Amim, Jorge Rezende Filho, Kevin M. Elias, Neil S. Horowitz, Sue Yazaki Sun, Ross S. Berkowitz

Summary: This study evaluated the efficacy of immunotherapy for GTN treatment and presented 4 Brazilian cases. The results showed that immunotherapy was effective for high-risk GTN, with pembrolizumab achieving a high therapeutic response despite prior chemoresistance to multiple lines of treatment.

CLINICS (2023)

Review Oncology

A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer

Anna V. V. Tinker, Neesha C. Dhani, Prafull Ghatage, Deanna McLeod, Vanessa Samouelian, Stephen A. Welch, Alon D. Altman

Summary: This review provides evidence-based guidance on the use of immune checkpoint inhibitors (ICIs) alone or in combination with tyrosine kinase inhibitors (TKIs) for the treatment of pretreated advanced, persistent, or recurrent metastatic endometrial cancer. The study findings suggest that pembrolizumab plus lenvatinib is effective for unselected pretreated metastatic endometrial cancer, while pembrolizumab monotherapy is recommended for patients with DNA mismatch repair/microsatellite instability-high (MMRd/MSI-H) tumors.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2023)

Article Oncology

Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group Study

Christa Aubrey, Gregory R. Pond, Limor Helpman, Danielle Vicus, Laurie Elit, Marie Plante, Susie Lau, Janice S. Kwon, Alon D. Altman, Karla Willows, Tomer Feigenberg, Jeanelle Sabourin, Vanessa Samouelian, Laurence Bernard, Norah Cockburn, Nora-Beth Saunders, Sabrina Piedimonte, Ly-Ann Teo-Fortin, Soyoun Rachel Kim, Noor Sadeq, Ji-Hyun Jang, Sarah Shamiya, Gregg Nelson

Summary: Minimally invasive surgery for macroscopic cervical cancer leads to worse outcomes than open surgery, but preoperative conization may help mitigate the risk. This retrospective study examined oncologic outcomes in cervical cancer cases treated initially with conization and subsequent hysterectomy using either minimally invasive or open approaches. The study found no significant differences in recurrence-free survival or overall survival between the two surgical approaches. However, further studies are needed to confirm these findings.

CURRENT ONCOLOGY (2023)

No Data Available